95 related articles for article (PubMed ID: 24606860)
1. Does reluctance to deliver stereotactic body radiation therapy to the central chest result from meaningful inference?
Oskan F
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):975-7. PubMed ID: 24606860
[No Abstract] [Full Text] [Related]
2. Stereotactic ablative therapy and the central chest: in regard to Oskan.
Lo SS; Huang Z; Yuh WT; Mayr NA
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1143. PubMed ID: 25035225
[No Abstract] [Full Text] [Related]
3. Retrospective cohort study of bronchial doses and radiation-induced atelectasis after stereotactic body radiation therapy of lung tumors located close to the bronchial tree.
Karlsson K; Nyman J; Baumann P; Wersäll P; Drugge N; Gagliardi G; Johansson KA; Persson JO; Rutkowska E; Tullgren O; Lax I
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):590-5. PubMed ID: 24074933
[TBL] [Abstract][Full Text] [Related]
4. In reply to Lo et al.
Oskan F
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1143-1144. PubMed ID: 25035224
[No Abstract] [Full Text] [Related]
5. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.
Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK
Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260
[TBL] [Abstract][Full Text] [Related]
6. Dose and Volume of the Irradiated Main Bronchi and Related Side Effects in the Treatment of Central Lung Tumors With Stereotactic Radiotherapy.
Duijm M; Schillemans W; Aerts JG; Heijmen B; Nuyttens JJ
Semin Radiat Oncol; 2016 Apr; 26(2):140-8. PubMed ID: 27000511
[TBL] [Abstract][Full Text] [Related]
7. Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer.
Timmerman R; Galvin J; Michalski J; Straube W; Ibbott G; Martin E; Abdulrahman R; Swann S; Fowler J; Choy H
Acta Oncol; 2006; 45(7):779-86. PubMed ID: 16982540
[TBL] [Abstract][Full Text] [Related]
8. Failure mode and effect analysis for delivery of lung stereotactic body radiation therapy.
Perks JR; Stanic S; Stern RL; Henk B; Nelson MS; Harse RD; Mathai M; Purdy JA; Valicenti RK; Siefkin AD; Chen AM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1324-9. PubMed ID: 22197236
[TBL] [Abstract][Full Text] [Related]
9. [Stereotactic body radiation therapy for early non-small cell lung cancer].
Zhang HQ; Li MH; Yu JM
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):561-3. PubMed ID: 22325212
[No Abstract] [Full Text] [Related]
10. Stereotactic body radiation therapy for lung tumors: system-related issues and complications.
Gaspar LE
Clin Lung Cancer; 2007 Jan; 8(4):233. PubMed ID: 17311686
[No Abstract] [Full Text] [Related]
11. Stereotactic radiosurgery and radiation therapy for spinal tumors.
Lo SS; Chang EL; Yamada Y; Sloan AE; Suh JH; Mendel E
Expert Rev Neurother; 2007 Jan; 7(1):85-93. PubMed ID: 17187488
[TBL] [Abstract][Full Text] [Related]
12. Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy.
Hoppe BS; Huh S; Flampouri S; Nichols RC; Oliver KR; Morris CG; Mendenhall NP; Li Z
Radiother Oncol; 2010 Dec; 97(3):425-30. PubMed ID: 20934768
[TBL] [Abstract][Full Text] [Related]
13. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer.
Xia T; Li H; Sun Q; Wang Y; Fan N; Yu Y; Li P; Chang JY
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):117-25. PubMed ID: 16765528
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.
Hadziahmetovic M; Loo BW; Timmerman RD; Mayr NA; Wang JZ; Huang Z; Grecula JC; Lo SS
Discov Med; 2010 May; 9(48):411-7. PubMed ID: 20515609
[TBL] [Abstract][Full Text] [Related]
15. A radiation oncologist's and thoracic surgeon's view on the role of stereotactic ablative radiotherapy for operable lung cancer.
Timmerman RD; Fernando HC
Semin Thorac Cardiovasc Surg; 2013; 25(1):8-13. PubMed ID: 23800524
[TBL] [Abstract][Full Text] [Related]
16. Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT).
Stephans KL; Djemil T; Tendulkar RD; Robinson CG; Reddy CA; Videtic GM
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):974-80. PubMed ID: 21300453
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: report of the ASTRO Emerging Technology Committee.
Buyyounouski MK; Balter P; Lewis B; D'Ambrosio DJ; Dilling TJ; Miller RC; Schefter T; Tomé W; Harris EE; Price RA; Konski AA; Wallner PE
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):3-10. PubMed ID: 20643514
[No Abstract] [Full Text] [Related]
18. Stereotactic body radiation therapy for lung cancer: achievements and perspectives.
Hiraoka M; Matsuo Y; Takayama K
Jpn J Clin Oncol; 2010 Sep; 40(9):846-54. PubMed ID: 20670962
[TBL] [Abstract][Full Text] [Related]
19. CyberKnife radiosurgery for stage I lung cancer: results at 36 months.
Brown WT; Wu X; Fayad F; Fowler JF; Amendola BE; García S; Han H; de la Zerda A; Bossart E; Huang Z; Schwade JG
Clin Lung Cancer; 2007 Sep; 8(8):488-92. PubMed ID: 17922973
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness research in radiation oncology: stereotactic radiosurgery, hypofractionation, and brachytherapy.
Aneja S; Yu JB
Semin Radiat Oncol; 2014 Jan; 24(1):35-42. PubMed ID: 24314340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
